Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
Bausch + Lomb Corporation (BLCO) Q1 2026 Earnings Call Transcript
Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
Bausch + Lomb Releases 2025 Sustainability Impact Report
Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
Comparing Biodesix (NASDAQ:BDSX) & Bausch + Lomb (NYSE:BLCO)
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
Bausch + Lomb Corporation (NYSE:BLCO) Receives Average Rating of “Hold” from Analysts
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29
Bausch + Lomb Corporation (NYSE:BLCO) Short Interest Up 50.7% in March
A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story
Bausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios Transcript
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
Bausch + Lomb Corporation Investigated by the Portnoy Law Firm
Bausch + Lomb Corporation Investigated by the Portnoy Law Firm
Eye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position
Bausch + Lomb Launches R&D “Teach-in” Webinar Series
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats
Bausch + Lomb (BLCO) Upgraded to Buy: Here's What You Should Know
Bausch + Lomb (NYSE:BLCO) Shares Gap Down Following Weak Earnings
Bausch + Lomb Corporation (BLCO) Q4 2025 Earnings Call Transcript
Bausch + Lomb (BLCO) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Bausch + Lomb (BLCO) Lags Q4 Earnings Estimates
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
Ahead of Bausch + Lomb (BLCO) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
BLCO or DHR: Which Is the Better Value Stock Right Now?
BLCO vs. HQY: Which Stock Is the Better Value Option?
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Bausch + Lomb Announces Two Board of Directors Appointments
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents at Citi Annual Global Healthcare Conference 2025 Transcript
BLCO Stock Still 16% Below IPO — Is Silver Point's $38.7 Million Bet a Turning Point?
Bausch + Lomb to Participate in Citi Global Healthcare Conference
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation - Analyst/Investor Day Transcript
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program
Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of “Hold” by Analysts
Bausch + Lomb Corporation (BLCO) Q3 2025 Earnings Call Transcript
Bausch + Lomb (BLCO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Bausch + Lomb (BLCO) Q3 Earnings Beat Estimates
Bausch + Lomb Announces Third-Quarter 2025 Results